Analyzing the Parkinson's disease clinical trial pipeline to facilitate patient collaboration in research.



For greater clarity into the types of PD trials underway, the set of active trials (currently ~500 interventional) can be segmented into portfolios based on various trial characteristics (e.g., disease-modifying, symptomatic, biomarker).  The resulting portfolios can then be accessed via direct links to, which has filter, search and download features that can be used to further drill-down into the trial data.  A portfolio would technically be constructed as a set of trial ID's (NCT#'s), in the same way that a stock portfolio can be represented as set of stock id#'s.

Trial subportfolios can also be created for further granularity (gene therapy, stem cell therapy, repurposed compounds, etc.)  A given trial could appear in more than one portfolio/subportfolio.


Select Country, State (U.S. only), City, and Distance.

Sample filters available on 

Studies with no phase specified may include evaluations of interventions such as exercise, physical therapy, speech therapy, dietary supplements and more.

* 30 trials are combined Phase 1/Phase 2 OR combined Phase 2/3.

(page under development)